Buffalo, NY – According to filings with the U.S. Securities and Exchange Commission, 22nd Century Group is raising $58,003,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, James Mish played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 22nd Century Group
22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. Our primary mission in tobacco is to reduce the harm caused by smoking by bringing our reduced nicotine content tobacco cigarettes containing 95% less nicotine than conventional cigarettes to adult smokers in the U.S. and international markets. Our mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

To learn more about 22nd Century Group, visit http://www.xxiicentury.com/

Contact:
James Mish, Chief Executive Officer
716-270-1523
jmish@xxiicentury.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved